| 001 | 154460 | ||
| 005 | 20240229123102.0 | ||
| 024 | 7 | _ | |a 10.1016/j.jtho.2020.03.023 |2 doi |
| 024 | 7 | _ | |a pmid:32272161 |2 pmid |
| 024 | 7 | _ | |a 1556-0864 |2 ISSN |
| 024 | 7 | _ | |a 1556-1380 |2 ISSN |
| 024 | 7 | _ | |a altmetric:79389994 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2020-00782 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Kim-Wanner, Soo-Zin |0 P:(DE-HGF)0 |b 0 |e First author |
| 245 | _ | _ | |a Genome-wide DNA methylation profiling in early stage I lung adenocarcinoma reveals predictive aberrant methylation in the promoter region of the long non-coding RNA PLUT - an exploratory study. |
| 260 | _ | _ | |a Amsterdam |c 2020 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1600865783_5651 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2020 Aug;15(8):1338-1350#EA:B370# |
| 520 | _ | _ | |a Surgery is the treatment of choice in early stage I lung adenocarcinoma. However, a considerable portion of patients experience recurrence within the first two years following complete resection. Especially suitable prognostic biomarkers are not available that identify patients at high risk for recurrence who may probably benefit from adjuvant treatment. This study aimed to identify methylation markers for early recurrence that may become important tools for the development of new treatment modalities.Genome-wide DNA methylation profiling was performed on 30 stage I lung adenocarcinomas comparing 14 patients with early metastatic recurrence to 16 patients with a long-term relapse-free survival period using methylated-CpG-immunoprecipitation (MCIp) followed by high-throughput next generation sequencing. The differentially methylated regions (DMRs) between the two subgroups were validated for their prognostic value in two independent cohorts using the MassCleave Assay, a high-resolution quantitative methylation analysis.Unsupervised clustering of patients in the discovery cohort based on DMRs identified patients with shorter relapse free survival (HR 2.23; 95% CI 0.66 to 7.53; p=0.03). In two validation cohorts promoter hypermethylation of the long non-coding RNA (lncRNA) PLUT was significantly associated with shorter relapse free survival (HR 0.54; 95% CI 0.31 to 0.93; p<0.026) and could be shown to be an independent prognostic factor in the multivariate cox regression analysis.Promoter hypermethylation of the lncRNA PLUT is predictive in patients with early stage I adenocarcinoma at high risk for early recurrence. Further studies are needed to validate its role in carcinogenesis and its use as a biomarker to facilitate patient selection and risk stratification. |
| 536 | _ | _ | |a 312 - Functional and structural genomics (POF3-312) |0 G:(DE-HGF)POF3-312 |c POF3-312 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Assenov, Yassen |0 P:(DE-He78)45a6854ecf41ba2e65ca3ba0d560f14c |b 1 |
| 700 | 1 | _ | |a Nair, Mridul B |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Weichenhan, Dieter |0 P:(DE-He78)ff4024f7bc236e7897d9c18ee19c451f |b 3 |u dkfz |
| 700 | 1 | _ | |a Benner, Axel |0 P:(DE-He78)e15dfa1260625c69d6690a197392a994 |b 4 |u dkfz |
| 700 | 1 | _ | |a Becker, Natalia |0 P:(DE-He78)ecb33fb615e08035fdcefcaebfdff8f0 |b 5 |
| 700 | 1 | _ | |a Landwehr, Katharina |b 6 |
| 700 | 1 | _ | |a Kuner, Ruprecht |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Sültmann, Holger |0 P:(DE-He78)7483734fd8ab316391aa604c95f0e98a |b 8 |u dkfz |
| 700 | 1 | _ | |a Esteller, Manel |b 9 |
| 700 | 1 | _ | |a Koch, Ina |b 10 |
| 700 | 1 | _ | |a Lindner, Michael |b 11 |
| 700 | 1 | _ | |a Meister, Michael |b 12 |
| 700 | 1 | _ | |a Thomas, Michael |b 13 |
| 700 | 1 | _ | |a Bieg, Matthias |0 P:(DE-He78)e247efc0264a7b0e4bae09804002d4e1 |b 14 |u dkfz |
| 700 | 1 | _ | |a Klingmueller, Ursula |0 P:(DE-HGF)0 |b 15 |
| 700 | 1 | _ | |a Schlesner, Matthias |0 P:(DE-He78)f2a782242acf94a3114d75c45dc75b37 |b 16 |u dkfz |
| 700 | 1 | _ | |a Warth, Arne |b 17 |
| 700 | 1 | _ | |a Brors, Benedikt |0 P:(DE-He78)fc949170377b58098e46141d95c72661 |b 18 |u dkfz |
| 700 | 1 | _ | |a Seifried, Erhard |b 19 |
| 700 | 1 | _ | |a Bonig, Halvard |b 20 |
| 700 | 1 | _ | |a Plass, Christoph |0 P:(DE-He78)4301875630bc997edf491c694ae1f8a9 |b 21 |u dkfz |
| 700 | 1 | _ | |a Risch, Angela |0 P:(DE-He78)4981f4ef151aea881f38b33df8e35a21 |b 22 |u dkfz |
| 700 | 1 | _ | |a Muley, Thomas |b 23 |
| 773 | _ | _ | |a 10.1016/j.jtho.2020.03.023 |g p. S1556086420302872 |0 PERI:(DE-600)2223437-8 |n 8 |p 1338-1350 |t Journal of thoracic oncology |v 15 |y 2020 |x 1556-0864 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:154460 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)45a6854ecf41ba2e65ca3ba0d560f14c |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)ff4024f7bc236e7897d9c18ee19c451f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)e15dfa1260625c69d6690a197392a994 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)ecb33fb615e08035fdcefcaebfdff8f0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)7483734fd8ab316391aa604c95f0e98a |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 14 |6 P:(DE-He78)e247efc0264a7b0e4bae09804002d4e1 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)f2a782242acf94a3114d75c45dc75b37 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)fc949170377b58098e46141d95c72661 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-He78)4301875630bc997edf491c694ae1f8a9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)4981f4ef151aea881f38b33df8e35a21 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |2 G:(DE-HGF)POF3-300 |v Functional and structural genomics |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a Allianz-Lizenz |0 StatID:(DE-HGF)0410 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J THORAC ONCOL : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b J THORAC ONCOL : 2017 |
| 920 | 0 | _ | |0 I:(DE-He78)B370-20160331 |k B370 |l Epigenomik |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B370-20160331 |k B370 |l Epigenomik |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)C060-20160331 |k C060 |l C060 Biostatistik |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)B063-20160331 |k B063 |l B063 Krebsgenomforschung |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)FM01-20160331 |k FM01 |l DKTK FM zentral |x 4 |
| 920 | 1 | _ | |0 I:(DE-He78)B080-20160331 |k B080 |l B080 Theoretische Bioinformatik |x 5 |
| 920 | 1 | _ | |0 I:(DE-He78)B200-20160331 |k B200 |l B200 Systembiologie der Signaltransduktion |x 6 |
| 920 | 1 | _ | |0 I:(DE-He78)B330-20160331 |k B330 |l Angewandte Bioinformatik |x 7 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B370-20160331 |
| 980 | _ | _ | |a I:(DE-He78)C060-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B063-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a I:(DE-He78)FM01-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B080-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B200-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B330-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|
guest ::